Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kinetin is a naturally occurring cytokinin—a class of plant hormones—that promotes cell division and growth in plants. It was originally isolated as a plant hormone but has since been found in DNA from various organisms including humans. In medicine and cosmetics, kinetin is primarily used topically for its purported anti-aging effects on the skin such as reducing roughness and fine wrinkles; however, clinical evidence supporting these uses is limited[1][2][8]. Potential oral uses include treatment of genetic disorders like familial dysautonomia and certain cancers[2]. Mechanistically in mammalian cells it may act as an antioxidant—protecting DNA from oxidative damage—and can modulate cellular processes by binding to the adenosine receptor (A2a-R)[5][6]. Its precise mechanism of action remains unclear but includes antioxidative activity and possible stimulation of DNA repair pathways[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kinetin.